<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clinics (Sao Paulo)</journal-id><journal-id journal-id-type="iso-abbrev">Clinics (Sao Paulo)</journal-id><journal-title-group><journal-title>Clinics</journal-title></journal-title-group><issn pub-type="ppub">1807-5932</issn><issn pub-type="epub">1980-5322</issn><publisher><publisher-name>Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23917662</article-id><article-id pub-id-type="pmc">3714857</article-id><article-id pub-id-type="doi">10.6061/clinics/2013(07)14</article-id><article-id pub-id-type="publisher-id">cln_68p974</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Science</subject></subj-group></article-categories><title-group><article-title>Exercise prescription using the heart of claudication pain onset in patients with intermittent claudication</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cucato</surname><given-names>Gabriel Grizzo</given-names></name><xref ref-type="aff" rid="af1-cln_68p974">I</xref></contrib><contrib contrib-type="author"><name><surname>da Rocha Chehuen</surname><given-names>Marcel</given-names></name><xref ref-type="aff" rid="af1-cln_68p974">I</xref></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>Luis Augusto Riani</given-names></name><xref ref-type="aff" rid="af1-cln_68p974">I</xref></contrib><contrib contrib-type="author"><name><surname>Ritti-Dias</surname><given-names>Raphael Mendes</given-names></name><xref ref-type="aff" rid="af2-cln_68p974">II</xref></contrib><contrib contrib-type="author"><name><surname>Wolosker</surname><given-names>Nelson</given-names></name><xref ref-type="aff" rid="af3-cln_68p974">III</xref></contrib><contrib contrib-type="author"><name><surname>Saxton</surname><given-names>John Michael</given-names></name><xref ref-type="aff" rid="af4-cln_68p974">IV</xref></contrib><contrib contrib-type="author"><name><surname>de Moraes Forjaz</surname><given-names>Cl&#x000e1;udia L&#x000fa;cia</given-names></name><xref ref-type="aff" rid="af1-cln_68p974">I</xref></contrib><aff id="af1-cln_68p974"><label>I</label>Universidade de S&#x000e3;o Paulo, Exercise Hemodynamic Laboratory, School of Physical Education and Sport, S&#x000e3;o Paulo/SP, Brazil. </aff><aff id="af2-cln_68p974"><label>II</label>Universidade de Pernambuco, School of Physical Education, Recife/PE, Brazil. </aff><aff id="af3-cln_68p974"><label>III</label>Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo, Division of Vascular Surgery, Ambulatory of Intermittent Claudication, S&#x000e3;o Paulo/SP, Brazil. </aff><aff id="af4-cln_68p974"><label>IV</label>University of East Anglia, School Of Allied Health Professions, Norwich, United Kingdom. </aff></contrib-group><author-notes><fn fn-type="con"><p>Cucato GG held overall responsibility for the study and was responsible for the following items: study conception and design, statistical analysis, data collection and interpretation, manuscript writing and approval of the final version of the manuscript. Chehuen MR was responsible for the following items: study conception and design, statistical analysis, data interpretation and collection, manuscript writing and approval of the final version of the manuscript. Costa LA was responsible for data collection and approval of the final version of the manuscript. Dias RM and Wolosker N were responsible for writing the manuscript and approval of the final version of the manuscript. Saxton JM was responsible for manuscript writing, critical revision of the manuscript, and approval of the final version of the manuscript. Moraes CL held overall responsibility for the study and was responsible for the study conception and design, obtaining funding, statistical analysis and data interpretation, writing and critical revision of the manuscript and approval of the final version of the manuscript.</p></fn><corresp id="c1-cln_68p974">E-mail: <email>cforjaz@usp.br</email> Tel.: <phone>55 11 3091-3136</phone></corresp></author-notes><pub-date pub-type="ppub"><month>7</month><year>2013</year></pub-date><volume>68</volume><issue>7</issue><fpage>974</fpage><lpage>978</lpage><history><date date-type="received"><day>4</day><month>2</month><year>2013</year></date><date date-type="rev-recd"><day>22</day><month>2</month><year>2013</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Hospital das Cl&#x000ed;nicas da FMUSP</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>OBJECTIVE:</title><p>To assess the acute metabolic and cardiovascular responses to walking exercise at an intensity corresponding to the heart rate of claudication pain onset and to investigate the effects of a 12-week walking training program at this intensity on walking capacity.</p></sec><sec><title>METHODS:</title><p>Twenty-nine patients with intermittent claudication were randomly allocated to the walking training (n&#x0200a;=&#x0200a;17) or control (CO, n&#x0200a;=&#x0200a;12) group. The walking training group performed an acute exercise session comprising 15&#x000d7;2-min bouts of walking at the heart rate of claudication pain onset, with 2-min interpolated rest intervals. The claudication symptoms and cardiovascular and metabolic responses were evaluated. Walking training was then performed at the same intensity twice each week for 12 weeks, while the control group engaged in twice weekly stretching classes. The claudication onset distance and total walking distance were evaluated before and after the interventions. Brazilian Registry Clinical Trials: RBR-7M3D8W.</p></sec><sec><title>RESULTS:</title><p>During the acute exercise session, the heart rate was maintained within tight limits. The exercise intensity was above the anaerobic threshold and &#x0003e;80% of the heart rate peak and VO<sub>2peak</sub>. After the exercise training period, the walking exercise group (n&#x0200a;=&#x0200a;13) showed increased claudication onset distance (309&#x000b1;153 <italic>vs</italic>. 413&#x000b1;201m) and total walking distance (784&#x000b1;182 <italic>vs</italic>. 1,100&#x000b1;236m) compared to the control group (n&#x0200a;=&#x0200a;12) (<italic>p</italic>&#x0003c;0.05).</p></sec><sec><title>CONCLUSION:</title><p>Walking exercise prescribed at the heart rate of claudication pain onset enables patients with intermittent claudication to exercise with tolerable levels of pain and improves walking performance.</p></sec></abstract><kwd-group><kwd>Peripheral Artery Disease</kwd><kwd>Functional Capacity</kwd><kwd>Exercise Intensity</kwd><kwd>Cardiovascular System</kwd><kwd>Metabolism</kwd></kwd-group><counts><page-count count="5"/></counts></article-meta></front><body><sec><title>INTRODUCTION</title><p>Walking exercise is recommended for patients with intermittent claudication (<xref ref-type="bibr" rid="b1-cln_68p974">1</xref>,<xref ref-type="bibr" rid="b2-cln_68p974">2</xref>) because it improves the claudication onset distance and total walking distance. However, the degree of improvement varies according to different studies (<xref ref-type="bibr" rid="b3-cln_68p974">3</xref>); this discrepancy might be explained by different exercise prescriptions that vary in intensity, duration and total amount of exercise prescribed (<xref ref-type="bibr" rid="b3-cln_68p974">3</xref>&#x02013;<xref ref-type="bibr" rid="b5-cln_68p974">5</xref>).</p><p>Guidelines recommend that walking exercise should be performed at an intensity that elicits claudication symptoms within 3 to 5 min (<xref ref-type="bibr" rid="b1-cln_68p974">1</xref>,<xref ref-type="bibr" rid="b2-cln_68p974">2</xref>). However, the intensity of exercise needed to elicit claudication symptoms in 3 min is greater than that needed to elicit symptoms in 5 min. Hence, because of the variability in exercise training prescriptions, it is difficult to understand the impact of exercise training intensity on the changes in walking performance in this patient group and the discrepant results among different trials (<xref ref-type="bibr" rid="b6-cln_68p974">6</xref>,<xref ref-type="bibr" rid="b7-cln_68p974">7</xref>). Furthermore, the guidelines recommend that patients walk until they achieve claudication of moderate severity before resting briefly and repeating the exercise (<xref ref-type="bibr" rid="b2-cln_68p974">2</xref>). However, this approach could prevent patients from engaging in exercise rehabilitation because of the level of pain experienced.</p><p>We have previously demonstrated in patients with intermittent claudication that claudication pain onset assessed during a graded treadmill test occurred at an intensity that was higher than the individual's anaerobic threshold (<xref ref-type="bibr" rid="b8-cln_68p974">8</xref>). Exercise above the anaerobic threshold is known to be an effective stimulus for inducing metabolic and cardiovascular adaptations (<xref ref-type="bibr" rid="b9-cln_68p974">9</xref>); therefore, exercise at this intensity could effectively improve the walking capacities of patients with intermittent claudication.</p><p>Walking exercise above the anaerobic threshold has previously been prescribed for patients with cardiovascular disease, and heart rate was used to prescribe and monitor the exercise intensity (<xref ref-type="bibr" rid="b10-cln_68p974">10</xref>). However, using heart rate to control exercise intensity in patients with intermittent claudication, whose capacity to exercise is limited by ischemic leg pain, has not been previously investigated.</p><p>The present study, which was designed to test the feasibility and efficacy of using the heart rate of claudication pain onset to prescribe walking exercise for patients with intermittent claudication, was the first step in analyzing the utility of this type of exercise prescription. Thus, the purpose of this study was to analyze the pain, cardiovascular and metabolic responses experienced by patients during walking exercise performed at the heart rate corresponding to the claudication pain onset, and to investigate the effects of a 12-week walking training program at this intensity on walking capacity in patients with intermittent claudication. We hypothesized that an exercise prescription at this intensity would elicit tolerable claudication symptoms, while inducing an exercise training stimulus above the individual's anaerobic threshold. Second, we hypothesized that a low-volume walking exercise training program at this intensity would induce walking performance improvements in this patient group.</p></sec><sec sec-type="materials|methods"><title>MATERIAL AND METHODS</title><p>This study was approved by the Ethics Committee of the School of Physical Education and Sport of University of S&#x000e3;o Paulo (process 2008/55) and was registered in the Brazilian Registry of Clinical Trials (RBR-7M3D8W). Patients with stable symptoms of intermittent claudication were recruited from a tertiary center specializing in vascular disease. Male patients with Fontaine stage II symptoms of intermittent claudication for more than 6 months, an ankle-brachial index &#x02264;0.90 at rest in 1 or 2 legs and who were able to walk for at least 2 min at 3.2 km/h on a treadmill were invited to participate. The following exclusion criteria were applied: obesity (body mass index &#x02265;30 kg/m<sup>2</sup>), use of &#x003b2;-blockers, non-dihydropyridine calcium channel blockers, or peripheral vasodilators, inability to obtain the ankle-brachial index, exercise tolerance limited by factors other than claudication (i.e., arrhythmias, cardiac symptoms or exaggerated blood pressure rise), electrocardiogram response suggestive of myocardial ischemia and history of revascularization in the previous year.</p><p>Twenty-nine patients participated in the study and were randomized into 2 groups: the walking training group (n&#x0200a;=&#x0200a;17) and the control group (n&#x0200a;=&#x0200a;12). The study comprised 2 phases. In phase 1, during an acute walking exercise session conducted at intensity of heart rate of claudication pain onset, the cardiopulmonary responses and claudication symptoms were assessed in the patients who were randomized to walking training. In phase 2, the patients in the walking training group engaged in twice-weekly walking exercise training for 12 weeks, while patients in the control group engaged in stretching exercise classes for the same amount of time. Both groups were evaluated at the beginning and end of the 12-week period.</p><sec><title>Maximal graded treadmill test</title><p>All patients performed a progressive graded treadmill exercise test to maximum claudication pain at baseline and after 12 weeks. Speed was maintained at 3.2 km/h, and the grade was increased by 2% every 2 min (<xref ref-type="bibr" rid="b11-cln_68p974">11</xref>). A 12-lead electrocardiogram was continuously monitored, and the heart rate was measured at the end of each stage. Oxygen uptake (VO<sub>2</sub>) was continuously measured using a metabolic cart (Medical Graphics Corp CPX/D, St Paul, Minnesota, USA), and the data were averaged over 30-s intervals for use in the analysis. The anaerobic threshold was independently detected by 2 evaluators; the threshold was defined by a nonlinear increase in the respiratory exchange ratio, carbon dioxide production and ventilation, and an increase in the end-tidal oxygen partial pressure and a decrease in the ventilatory equivalent for oxygen (<xref ref-type="bibr" rid="b12-cln_68p974">12</xref>). During the test, patients reported the onset of claudication symptoms, and the heart rate at this point was used for the walking exercise training prescription. Claudication onset distance and total walking distance were defined as the distance walked when the patient first reported leg pain and the distance at which the patient was unable to continue exercising because of leg pain, respectively (<xref ref-type="bibr" rid="b13-cln_68p974">13</xref>,<xref ref-type="bibr" rid="b14-cln_68p974">14</xref>).</p></sec><sec><title>Phase 1: Acute exercise responses</title><p>Patients in the walking training group performed a session of walking exercise that comprised 15&#x000d7;2-min walking bouts, with 2-min intermittent rest periods. During each of the 2-min walking bouts, exercise intensity was adjusted to maintain heart rate within 4 beats per minute (bpm) above or below the heart rate of claudication pain onset (e.g., if the patient reported the claudication pain onset in the maximal treadmill test at 100 bpm, the heart rate exercise zone was set at 96 to 104 bpm). The treadmill speed was set at 3.2 km/h, while the grade was adjusted to achieve the target heart rate, which was continuously monitored (Polar A3, Helsink, Uusimaa, Finland). In addition, the pain levels were monitored throughout the session, and VO<sub>2</sub> was measured during the 1<sup>st</sup>, 5<sup>th</sup> and 12<sup>th</sup> walking exercise bouts.</p></sec><sec><title>Phase 2: Exercise training intervention</title><p>Patients in the walking training group engaged in a twice-weekly 12-week walking exercise training program that consisted of the same protocol used in phase 1 of the study. Each session comprised 15&#x000d7;2-min walking exercise bouts at the heart rate of claudication pain onset &#x000b1; 4 bpm, with 2-min interpolated rest periods. In all exercise training sessions, the heart rate was continuously monitored. The walking speed was set at 3.2 km/h, and the grade was adjusted to maintain the heart rate within the target range. If the patient failed to reach the target heart rate during a particular walking exercise session, the treadmill grade was increased for the next session. Patients in the control group performed stretching exercises using the upper and lower limbs twice a week for 30 min per session.</p></sec><sec><title>Statistical analysis</title><p>Chi-squared tests and t-tests were used to compare the baseline characteristics of the groups. In phase 1, the acute responses to walking training were analyzed using a one-way analysis of variance (ANOVA). In phase 2, the claudication onset and total walking distances were compared between the groups using a two-way ANOVA; Newman-Keuls post-hoc tests were used to identify differences. Significance was set at <italic>p</italic>&#x0003c;0.05. The data are presented as the mean &#x000b1; standard deviation (SD).</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The clinical characteristics of the patients with intermittent claudication are shown in <xref ref-type="table" rid="t1-cln_68p974">Table&#x000a0;1</xref>. Baseline anthropometric and disease characteristics were similar between the walking training and control groups. Most patients were elderly, non-obese, hypertensive and were receiving anti-hypertensive, lipid-lowering and antiplatelet drug therapy.</p><p>The acute responses assessed during the walking exercise are presented in <xref ref-type="table" rid="t2-cln_68p974">Table&#x000a0;2</xref>. Heart rate was maintained at the target intensity throughout the acute exercise session (approximately 100% of the heart rate of claudication pain onset). In comparison with the resting values, both the VO<sub>2</sub> and heart rate increased during the 1<sup>st</sup>, 5<sup>th</sup> and 12<sup>th</sup> exercise bouts. After the 5<sup>th</sup> bout, the VO<sub>2</sub> and heart rate were &#x0003e;80% of the peak values recorded in the maximal graded treadmill test. After the 5<sup>th</sup> bout most patients reported experiencing tolerable claudication symptoms during walking. </p><p>Twenty-five patients completed phase 2 of the study. Four patients in the walking training group did not complete the training program for personal reasons. During the training program, heart rate was kept at the target intensity by increasing the treadmill grade as patients adapted to the exercise program. After 12 weeks, the claudication onset distance and total walking distance increased significantly (<italic>p</italic>&#x0003c;0.05) in the walking training group, while no change was observed in the control group (<xref ref-type="table" rid="t1-cln_68p974">Table&#x000a0;3</xref>).</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Although regular walking exercise is recommended as an initial treatment for many patients with intermittent claudication, the exercise prescription intensity is poorly defined in peripheral arterial disease guidelines (<xref ref-type="bibr" rid="b1-cln_68p974">1</xref>,<xref ref-type="bibr" rid="b2-cln_68p974">2</xref>). The results of the present study indicate that walking exercise prescribed at the heart rate corresponding to claudication pain onset induces tolerable levels of ischemic leg pain and a cardiopulmonary exercise stimulus that is above the anaerobic threshold. Previous studies have suggested that exercise intensities that evoke claudication symptoms are important for improving walking capacity (<xref ref-type="bibr" rid="b3-cln_68p974">3</xref>,<xref ref-type="bibr" rid="b7-cln_68p974">7</xref>), and an exercise stimulus which is above the anaerobic threshold is particularly effective for promoting cardiovascular and metabolic adaptations (<xref ref-type="bibr" rid="b9-cln_68p974">9</xref>,<xref ref-type="bibr" rid="b15-cln_68p974">15</xref>). Hence, our results show that a walking exercise prescription at the heart rate of claudication pain onset is consistent with the physiological evidence for optimal exercise training intensity to improve walking performance and aerobic exercise tolerance in this patient group. Furthermore, patients can exercise at this intensity without experiencing intolerable levels of ischemic leg pain.</p><p>This conclusion is supported by the patient responses to the exercise training program. Twelve hours of walking exercise at the heart rate of claudication pain onset spread over 12 weeks induced improvements (in the claudication onset distance and total walking distance) that were similar in magnitude to the improvements previously observed after higher volume walking exercise training programs in patients with intermittent claudication (<xref ref-type="bibr" rid="b16-cln_68p974">16</xref>&#x02013;<xref ref-type="bibr" rid="b18-cln_68p974">18</xref>). Claudication onset distance and total walking distance were increased by 104&#x000b1;141 m and 316&#x000b1;141 m, respectively, which represent clinically meaningful changes, particularly because our patient cohort had a higher walking capacity at baseline than that reported in previous studies (<xref ref-type="bibr" rid="b3-cln_68p974">3</xref>,<xref ref-type="bibr" rid="b5-cln_68p974">5</xref>,<xref ref-type="bibr" rid="b7-cln_68p974">7</xref>). Evidence from a previous meta-analysis suggests that for optimal improvements in walking capacity, exercise sessions should be &#x0003e;30 min in duration and should be performed at least 3 times per week for a minimum of 6 months (<xref ref-type="bibr" rid="b3-cln_68p974">3</xref>). Our evidence suggests that walking exercise prescribed at the heart rate corresponding to the claudication pain onset in the form of short bouts is an effective exercise training regimen that can induce walking performance improvements comparable to those of higher volume walking exercise programs in patients with intermittent claudication. Furthermore, exercise training at the heart rate of claudication pain onset is well tolerated by patients and can be easily controlled in the clinic or community setting using a heart rate monitor.</p><p>The present study had limitations. The proposed walking training protocol focused only on the exercise intensity; exercise duration and frequency may also influence responses to walking training. However, these parameters can be objectively stated and did not vary greatly between the studies. The present investigation did not include women and did not include patients who were using beta-blockers or non-dihydropyridine calcium channel blockers; thus, the results cannot be extrapolated to patients with intermittent claudication with those characteristics. In addition, we did not include patients using vasodilators, such as cilostazol, which are used by some patients and might improve walking distance. Thus, the results might change with vasodilator treatment, which should be tested in the future. Finally, in this study, our control group followed another type of training and did not employ the traditional walking prescription for intermittent claudication patients. Therefore, it was not possible to determine whether this study's exercise protocol was better than, equal to or worse than others. This study was intended to be the first step in verifying whether the protocol as feasible and resulted in walking improvements. Future research should compare this protocol with other classical training protocols.</p><p>In conclusion, walking exercise prescribed at an intensity corresponding to the heart rate of claudication pain onset induces tolerable levels of ischemic leg pain and a cardiopulmonary exercise training stimulus that is above the anaerobic threshold (&#x0003e;80% of peak aerobic capacity). A short-term, low-volume exercise training program at this intensity is effective in evoking clinically meaningful improvements in walking performance in this patient group. Hence, the heart rate of claudication pain onset may be useful for optimizing exercise prescriptions in patients with intermittent claudication.</p></sec><sec><title>Acknowledgments</title><p>This research was supported by Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (2009&#x02013;17371-6), Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (141057/2011-4) and Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (0851/12-4). In addition, the authors would like to thank the study volunteers for their participation.</p></sec></body><back><fn-group><fn fn-type="conflict"><p>No potential conflict of interest was reported.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="b1-cln_68p974"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Norgren</surname><given-names>L</given-names></name><name><surname>Hiatt</surname><given-names>WR</given-names></name><name><surname>Dormandy</surname><given-names>JA</given-names></name><name><surname>Nehler</surname><given-names>MR</given-names></name><name><surname>Harris</surname><given-names>KA</given-names></name><name><surname>Fowkes</surname><given-names>FG</given-names></name><etal/></person-group><article-title>Inter-society consensus for the management of peripheral arterial disease</article-title><source>Int Angiol</source><year>2007</year><volume>26(2)</volume><fpage>81</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">17489079</pub-id></element-citation></ref><ref id="b2-cln_68p974"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>AT</given-names></name><name><surname>Haskal</surname><given-names>ZJ</given-names></name><name><surname>Hertzer</surname><given-names>NR</given-names></name><name><surname>Bakal</surname><given-names>CW</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name><name><surname>Halperin</surname><given-names>JL</given-names></name><etal/></person-group><article-title>ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation</article-title><source>Circulation</source><year>2006</year><volume>113(11)</volume><fpage>e463</fpage><lpage>654</lpage><pub-id pub-id-type="pmid">16549646</pub-id></element-citation></ref><ref id="b3-cln_68p974"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gardner</surname><given-names>AW</given-names></name><name><surname>Poehlman</surname><given-names>ET</given-names></name></person-group><article-title>Exercise rehabilitation programs for the treatment of claudication pain</article-title><source>A&#x000a0;meta-analysis. JAMA</source><year>1995</year><volume>274(12)</volume><fpage>975</fpage><lpage>80</lpage></element-citation></ref><ref id="b4-cln_68p974"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parmenter</surname><given-names>BJ</given-names></name><name><surname>Raymond</surname><given-names>J</given-names></name><name><surname>Fiatarone Singh</surname><given-names>MA</given-names></name></person-group><article-title>The effect of exercise on haemodynamics in intermittent claudication: a systematic review of randomized controlled trials</article-title><source>Sports Med</source><year>2010</year><volume>40(5)</volume><fpage>433</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">20433214</pub-id></element-citation></ref><ref id="b5-cln_68p974"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bendermacher</surname><given-names>BL</given-names></name><name><surname>Willigendael</surname><given-names>EM</given-names></name><name><surname>Teijink</surname><given-names>JA</given-names></name><name><surname>Prins</surname><given-names>MH</given-names></name></person-group><article-title>Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication</article-title><source>Cochrane Database Syst Rev</source><year>2006</year><volume>(2)</volume><fpage>CD005263</fpage><pub-id pub-id-type="pmid">16625633</pub-id></element-citation></ref><ref id="b6-cln_68p974"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fakhry</surname><given-names>F</given-names></name><name><surname>van de Luijtgaarden</surname><given-names>KM</given-names></name><name><surname>Bax</surname><given-names>L</given-names></name><name><surname>den Hoed</surname><given-names>PT</given-names></name><name><surname>Hunink</surname><given-names>MG</given-names></name><name><surname>Rouwet</surname><given-names>EV</given-names></name><etal/></person-group><article-title>Supervised walking therapy in patients with intermittent claudication</article-title><source>J&#x000a0;Vasc Surg</source><year>2012</year><volume>56(4)</volume><fpage>1132</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">23026425</pub-id></element-citation></ref><ref id="b7-cln_68p974"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parmenter</surname><given-names>BJ</given-names></name><name><surname>Raymond</surname><given-names>J</given-names></name><name><surname>Dinnen</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>MA</given-names></name></person-group><article-title>A systematic review of randomized controlled trials: Walking versus alternative exercise prescription as treatment for intermittent claudication</article-title><source>Atherosclerosis</source><year>2011</year><volume>218(1)</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">21601857</pub-id></element-citation></ref><ref id="b8-cln_68p974"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ritti-Dias</surname><given-names>RM</given-names></name><name><surname>de Moraes Forjaz</surname><given-names>CL</given-names></name><name><surname>Cucato</surname><given-names>GG</given-names></name><name><surname>Costa</surname><given-names>LA</given-names></name><name><surname>Wolosker</surname><given-names>N</given-names></name><name><surname>de Fatima Nunes Marucci</surname><given-names>M</given-names></name></person-group><article-title>Pain threshold is achieved at intensity above anaerobic threshold in patients with intermittent claudication</article-title><source>J&#x000a0;Cardiopulm Rehabil Prev</source><year>2009</year><volume>29(6)</volume><fpage>396</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">19770807</pub-id></element-citation></ref><ref id="b9-cln_68p974"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henritze</surname><given-names>J</given-names></name><name><surname>Weltman</surname><given-names>A</given-names></name><name><surname>Schurrer</surname><given-names>R</given-names></name><name><surname>Barlow</surname><given-names>K</given-names></name></person-group><article-title>Effects of training at and above the lactate threshold on the lactate threshold and maximal oxygen uptake</article-title><source>Eur&#x000a0;J&#x000a0;Appl Physiol Occup Physiol</source><year>1985</year><volume>54(1)</volume><fpage>84</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">4018061</pub-id></element-citation></ref><ref id="b10-cln_68p974"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gordon</surname><given-names>NF</given-names></name><name><surname>Scott</surname><given-names>CB</given-names></name></person-group><article-title>Exercise intensity prescription in cardiovascular disease</article-title><source>Theoretical basis for anaerobic threshold determination.&#x000a0;J&#x000a0;Cardiopulm Rehabil</source><year>1995</year><volume>15(3)</volume><fpage>193</fpage><lpage>6</lpage></element-citation></ref><ref id="b11-cln_68p974"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gardner</surname><given-names>AW</given-names></name><name><surname>Skinner</surname><given-names>JS</given-names></name><name><surname>Cantwell</surname><given-names>BW</given-names></name><name><surname>Smith</surname><given-names>LK</given-names></name></person-group><article-title>Progressive vs single-stage treadmill tests for evaluation of claudication</article-title><source>Med Sci Sports Exerc</source><year>1991</year><volume>23(4)</volume><fpage>402</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2056896</pub-id></element-citation></ref><ref id="b12-cln_68p974"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wasserman</surname><given-names>K</given-names></name><name><surname>Whipp</surname><given-names>BJ</given-names></name><name><surname>Koyl</surname><given-names>SN</given-names></name><name><surname>Beaver</surname><given-names>WL</given-names></name></person-group><article-title>Anaerobic threshold and respiratory gas exchange during exercise</article-title><source>J&#x000a0;Appl Physiol</source><year>1973</year><volume>35(2)</volume><fpage>236</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">4723033</pub-id></element-citation></ref><ref id="b13-cln_68p974"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ritti-Dias</surname><given-names>RM</given-names></name><name><surname>Wolosker</surname><given-names>N</given-names></name><name><surname>de Moraes Forjaz</surname><given-names>CL</given-names></name><name><surname>Carvalho</surname><given-names>CR</given-names></name><name><surname>Cucato</surname><given-names>GG</given-names></name><name><surname>Leao</surname><given-names>PP</given-names></name><etal/></person-group><article-title>Strength training increases walking tolerance in intermittent claudication patients: randomized trial</article-title><source>J&#x000a0;Vasc Surg</source><year>2010</year><volume>51(1)</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">19837534</pub-id></element-citation></ref><ref id="b14-cln_68p974"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>da Rocha Chehuen</surname><given-names>M</given-names></name><name><surname>Cucato</surname><given-names>G</given-names></name><name><surname>Dos Anjos Souza Barbosa</surname><given-names>J</given-names></name><name><surname>Costa</surname><given-names>L</given-names></name><name><surname>Ritti-Dias</surname><given-names>R</given-names></name><name><surname>Wolosker</surname><given-names>N</given-names></name><etal/></person-group><article-title>Ventilatory threshold is related to walking tolerance in patients with intermittent claudication</article-title><source>Vasa</source><year>2012</year><volume>41(4)</volume><fpage>275</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">22825861</pub-id></element-citation></ref><ref id="b15-cln_68p974"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Belman</surname><given-names>MJ</given-names></name><name><surname>Gaesser</surname><given-names>GA</given-names></name></person-group><article-title>Exercise training below and above the lactate threshold in the elderly</article-title><source>Med Sci Sports Exerc</source><year>1991</year><volume>23(5)</volume><fpage>562</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2072834</pub-id></element-citation></ref><ref id="b16-cln_68p974"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gardner</surname><given-names>AW</given-names></name><name><surname>Katzel</surname><given-names>LI</given-names></name><name><surname>Sorkin</surname><given-names>JD</given-names></name><name><surname>Killewich</surname><given-names>LA</given-names></name><name><surname>Ryan</surname><given-names>A</given-names></name><name><surname>Flinn</surname><given-names>WR</given-names></name><etal/></person-group><article-title>Improved functional outcomes following exercise rehabilitation in patients with intermittent claudication</article-title><source>J&#x000a0;Gerontol&#x000a0;A&#x000a0;Biol Sci Med Sci</source><year>2000</year><volume>55(10)</volume><fpage>M570</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11034229</pub-id></element-citation></ref><ref id="b17-cln_68p974"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gardner</surname><given-names>AW</given-names></name><name><surname>Montgomery</surname><given-names>PS</given-names></name><name><surname>Flinn</surname><given-names>WR</given-names></name><name><surname>Katzel</surname><given-names>LI</given-names></name></person-group><article-title>The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication</article-title><source>J&#x000a0;Vasc Surg</source><year>2005</year><volume>42(4)</volume><fpage>702</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16242558</pub-id></element-citation></ref><ref id="b18-cln_68p974"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tan</surname><given-names>KH</given-names></name><name><surname>Cotterrell</surname><given-names>D</given-names></name><name><surname>Sykes</surname><given-names>K</given-names></name><name><surname>Sissons</surname><given-names>GR</given-names></name><name><surname>de Cossart</surname><given-names>L</given-names></name><name><surname>Edwards</surname><given-names>PR</given-names></name></person-group><article-title>Exercise training for claudicants: changes in blood flow, cardiorespiratory status, metabolic functions, blood rheology and lipid profile</article-title><source>Eur&#x000a0;J&#x000a0;Vasc Endovasc Surg</source><year>2000</year><volume>20(1)</volume><fpage>72</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10906302</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-cln_68p974" position="float"><label>Table 1</label><caption><p>Clinical characteristics of the study patients.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Control (n&#x0200a;=&#x0200a;12)</td><td align="center" valign="top" rowspan="1" colspan="1">Walking training (n&#x0200a;=&#x0200a;13)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>p</italic>-value</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">61&#x000b1;8</td><td align="center" valign="top" rowspan="1" colspan="1">64&#x000b1;6</td><td align="center" valign="top" rowspan="1" colspan="1">0.39</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Weight (kg)</td><td align="center" valign="top" rowspan="1" colspan="1">74.1&#x000b1;13.6</td><td align="center" valign="top" rowspan="1" colspan="1">70.7&#x000b1;8.2</td><td align="center" valign="top" rowspan="1" colspan="1">0.54</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">25.9&#x000b1;3.8</td><td align="center" valign="top" rowspan="1" colspan="1">25.4&#x000b1;2.3</td><td align="center" valign="top" rowspan="1" colspan="1">0.73</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ABI at rest </td><td align="center" valign="top" rowspan="1" colspan="1">0.60&#x000b1;0.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.61&#x000b1;0.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.40</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Iliofemoral (%)</td><td align="center" valign="top" rowspan="1" colspan="1">50</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">0.69</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Femoropopliteal (%)</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">0.68</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tibiofibular (%)</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">0.99</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Claudication onset distance</td><td align="center" valign="top" rowspan="1" colspan="1">328&#x000b1;161</td><td align="center" valign="top" rowspan="1" colspan="1">309&#x000b1;153</td><td align="center" valign="top" rowspan="1" colspan="1">0.77</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total walking distance (m)</td><td align="center" valign="top" rowspan="1" colspan="1">828&#x000b1;286</td><td align="center" valign="top" rowspan="1" colspan="1">784&#x000b1;182</td><td align="center" valign="top" rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cardiovascular Risk Factors and Comorbidities</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Current smoking (%)</td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">0.34</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hypertension (%)</td><td align="center" valign="top" rowspan="1" colspan="1">83</td><td align="center" valign="top" rowspan="1" colspan="1">84</td><td align="center" valign="top" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Diabetes mellitus (%)</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">0.64</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dyslipidemia (%)</td><td align="center" valign="top" rowspan="1" colspan="1">100</td><td align="center" valign="top" rowspan="1" colspan="1">85</td><td align="center" valign="top" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Medication</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Antihypertensive agent (%)</td><td align="center" valign="top" rowspan="1" colspan="1">83</td><td align="center" valign="top" rowspan="1" colspan="1">84</td><td align="center" valign="top" rowspan="1" colspan="1">0.93</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Lipid-lowering agent (%)</td><td align="center" valign="top" rowspan="1" colspan="1">50</td><td align="center" valign="top" rowspan="1" colspan="1">77</td><td align="center" valign="top" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Anticoagulants/antiplatelet agent (%)</td><td align="center" valign="top" rowspan="1" colspan="1">92</td><td align="center" valign="top" rowspan="1" colspan="1">100</td><td align="center" valign="top" rowspan="1" colspan="1">0.28</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-cln_68p974"><p>Continuous variables are presented as the mean &#x000b1; SD.ABI &#x0200a;=&#x0200a; ankle brachial index.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-cln_68p974" position="float"><label>Table 2</label><caption><p>Cardiopulmonary responses and prevalence of claudication symptoms evaluated during a walking training session performed with the intensity prescribed at the heart rate of claudication pain onset (n&#x0200a;=&#x0200a;17).</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Rest</td><td align="center" valign="top" rowspan="1" colspan="1">1<sup>st</sup> bout</td><td align="center" valign="top" rowspan="1" colspan="1">5<sup>th</sup> bout</td><td align="center" valign="top" rowspan="1" colspan="1">12<sup>th</sup> bout</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">VO<sub>2</sub> (ml.kg<sup>&#x02212;1</sup>.min<sup>&#x02212;1</sup>) </td><td align="center" valign="top" rowspan="1" colspan="1">4.0&#x000b1;0.8</td><td align="center" valign="top" rowspan="1" colspan="1">12.0&#x000b1;3.3<xref ref-type="table-fn" rid="tfn3-cln_68p974">a</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">14.9&#x000b1;2.2<sup>ab</sup></td><td align="center" valign="top" rowspan="1" colspan="1">14.7&#x000b1;2.7<sup>ab</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VO<sub>2</sub> peak (%)</td><td align="center" valign="top" rowspan="1" colspan="1">22&#x000b1;7</td><td align="center" valign="top" rowspan="1" colspan="1">65&#x000b1;20<xref ref-type="table-fn" rid="tfn3-cln_68p974">a</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">81&#x000b1;16<sup>ab</sup></td><td align="center" valign="top" rowspan="1" colspan="1">80&#x000b1;16<sup>ab</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">VO<sub>2</sub> anaerobic threshold (%)</td><td align="center" valign="top" rowspan="1" colspan="1">32&#x000b1;9</td><td align="center" valign="top" rowspan="1" colspan="1">94&#x000b1;33<xref ref-type="table-fn" rid="tfn3-cln_68p974">a</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">117&#x000b1;27<sup>ab</sup></td><td align="center" valign="top" rowspan="1" colspan="1">114&#x000b1;27<sup>ab</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Heart rate (bpm)</td><td align="center" valign="top" rowspan="1" colspan="1">73&#x000b1;10</td><td align="center" valign="top" rowspan="1" colspan="1">94&#x000b1;13<xref ref-type="table-fn" rid="tfn3-cln_68p974">a</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">99&#x000b1;16<xref ref-type="table-fn" rid="tfn3-cln_68p974">a</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">101&#x000b1;16<xref ref-type="table-fn" rid="tfn3-cln_68p974">a</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Heart rate peak (%)</td><td align="center" valign="top" rowspan="1" colspan="1">60&#x000b1;13</td><td align="center" valign="top" rowspan="1" colspan="1">76&#x000b1;6<xref ref-type="table-fn" rid="tfn3-cln_68p974">a</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">81&#x000b1;8<xref ref-type="table-fn" rid="tfn3-cln_68p974">a</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">82&#x000b1;7<sup>ab</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Heart rate of claudication pain onset (%)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="top" rowspan="1" colspan="1">95&#x000b1;7</td><td align="center" valign="top" rowspan="1" colspan="1">100&#x000b1;3<xref ref-type="table-fn" rid="tfn4-cln_68p974">b</xref>)</td><td align="center" valign="top" rowspan="1" colspan="1">102&#x000b1;5<xref ref-type="table-fn" rid="tfn4-cln_68p974">b</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pain (% patients)</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02014;</td><td align="center" valign="top" rowspan="1" colspan="1">47</td><td align="center" valign="top" rowspan="1" colspan="1">94</td><td align="center" valign="top" rowspan="1" colspan="1">100</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-cln_68p974"><p>Continuous variables are presented as the mean &#x000b1; SD.</p></fn><fn id="tfn3-cln_68p974"><label>a</label><p>Significant difference from rest (<italic>p</italic>&#x0003c;0.05). </p></fn><fn id="tfn4-cln_68p974"><label>b</label><p>Significant difference from the 1<sup>st</sup> bout (<italic>p</italic>&#x0003c;0.05). VO<sub>2</sub>: oxygen uptake.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3-cln_68p974" position="float"><label>Table 3</label><caption><p>Walking performance in the exercise and control groups. Walking training was prescribed at the heart rate of claudication pain onset.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Pre</td><td align="center" valign="top" rowspan="1" colspan="1">Post</td><td align="center" valign="top" rowspan="1" colspan="1">Group effect</td><td align="center" valign="top" rowspan="1" colspan="1">Time effect</td><td align="center" valign="top" rowspan="1" colspan="1">Interaction effect</td></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Claudication onset distance (m)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Control group (n&#x0200a;=&#x0200a;12)</td><td align="center" valign="top" rowspan="1" colspan="1">328&#x000b1;161</td><td align="center" valign="top" rowspan="1" colspan="1">253&#x000b1;118</td><td align="center" valign="top" rowspan="1" colspan="1">0.24</td><td align="center" valign="top" rowspan="1" colspan="1">0.56</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Exercise training (n&#x0200a;=&#x0200a;13)</td><td align="center" valign="top" rowspan="1" colspan="1">309&#x000b1;153</td><td align="center" valign="top" rowspan="1" colspan="1">413&#x000b1;201<xref ref-type="table-fn" rid="tfn6-cln_68p974">*</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total walking distance (m)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Control group (n&#x0200a;=&#x0200a;12)</td><td align="center" valign="top" rowspan="1" colspan="1">828&#x000b1;286</td><td align="center" valign="top" rowspan="1" colspan="1">771&#x000b1;262</td><td align="center" valign="top" rowspan="1" colspan="1">0.14</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.01</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Exercise training (n&#x0200a;=&#x0200a;13)</td><td align="center" valign="top" rowspan="1" colspan="1">784&#x000b1;182</td><td align="center" valign="top" rowspan="1" colspan="1">1100&#x000b1;236<xref ref-type="table-fn" rid="tfn6-cln_68p974">*</xref>)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="tfn5-cln_68p975"><p>Continuous variables are presented as the mean &#x000b1; SD.</p></fn><fn id="tfn6-cln_68p974"><label>*</label><p>Significant difference from baseline (<italic>p</italic>&#x0003c;0.05).</p></fn></table-wrap-foot></table-wrap></floats-group></article>